METHOD FOR TREATMENT OF RECURRENT PREGNANCY LOSS RELATED TO RETROCHORIAL HEMATOMA Russian patent published in 2018 - IPC A61M1/02 A61K31/57 A61P43/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, specifically to obstetrics. Detect the retrochorial hematoma. Determine its size, carry out two-stage drug therapy with the use of dydrogesterone. In this case, after the first stage of therapy, after 5–7 days, the hematoma size change is monitored, and in the absence of a reduction in its size by at least 20 % or an increase in its size, compared with the initial one, a course of discrete plasmapheresis is carried out in an amount of 4–5 sessions with an interval of 2–3 days between sessions. In this case, 400–500 ml of plasma is removed in one session, after which the subsequent stage of drug treatment is performed.

EFFECT: method will ensure complete regression of the hematoma and the absence of recurrence or the emergence of new hematomas with resistance to complex medication, during the subsequent pregnancy period.

1 cl, 1 ex, 5 tbl